Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Time for some good news.
View:
Post by Infinity on Jun 13, 2022 8:39pm

Time for some good news.

I am hoping that the management would do something to bring up the stock price and the market cap.  They would need to release any news for that matter that show cases that the company is cruising in the right direction and the strategic plans that are in place are being worked dillgently.  Literally any development that would improve the image of the company as a serious contender for BTD and or AA.   I think the company cannot release any data on clinical studies at this point.  They can certainly release
1.  News on Strategic plans from the CEO and CFO, since RDW cannot comment openly.
2.  Progress report after shifting to Li Ka Shing Knowledge institute/ St Michaels Hospital.
3.  Immediate and future plans from Dr. Madzervic would be a bonus.  Now that she has been with the company for little under one year.  Her thoughts on the company's path to market the PDT as a viable alternative or supplemental program to BCG
4,  New contracts signed for device sales or Cool Laser Tech update. 
5. New clients enrolled and the growing number of Chiropractors and Physiotherapist who have started offering Cool laser as an integral part of any physical rehab programs.


This is required immediately to peg the down ward slide of the stock prices, improve investor sentimets!!
Comment by CancerSlayer on Jun 13, 2022 11:16pm
They have all hands on the NMIBC deck...as they should.  However, in the near term, the best remedy for any skeptical investor sentiment is not only the obvious = more durable response data, but also a clear presentation of that data.  In the context of having limited/BTD-worthy data, it would be helpful to see optimized & non-optimized data presented separately.  It would also ...more  
Comment by skys1 on Jun 14, 2022 9:45am
Agree SC, it would be nice to know the extent of the the Li Ka Shing relationship, however such discussions without firm agreements so as non-material, are often required to be discreet by either or both parties for many different reasons. 
Comment by ScienceFirst on Jun 14, 2022 10:00am
Skys1... I agree that chance are null that we hear about Li Ka Shing Institute if there's no official deal.   We have our Research Cancer Lab there, in order to deploy our technology to bedside and mainstream.  Not sure if the MedTech pharma of Li Ka Shing has its entries in urologist's offices, though they are into other cancer indications.
Comment by skys1 on Jun 14, 2022 10:25am
Yep ScienceFirst, I agree. The following is why I believe TLT wouldn't agree to any type of deal other than a no requirement type grant is because management knows that if they have aprovals to commercialize in hand, TLT is worth far more than without that very valuable status. Therefore with those approvals hopefully just several months away, agreeing to anything monetary would be foolish ...more  
Comment by gordo323 on Jun 14, 2022 11:08am
Big gap 0.295 Previous 10 Trades Time Size Price 10:45:34 10000 0.300 10:45:32 9000 0.305 10:43:54 6500 0.305 09:30:00 4500 0.295 09:30:00 500   Theralase Technologies Inc. (CA:TLT) ...more  
Comment by fecats on Jun 15, 2022 9:52am
Skys Sent you PM 
Comment by langosta on Jun 14, 2022 11:33am
A Lyric line in this song hits the mark.  Sometimes I get Disturbed by the Silence. "Silence like a cancer grows" https://youtu.be/Bk7RVw3I8eg
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250